VERA | Vera Therapeutics, Inc. Class ANASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$30.25
-$0.73 (-2.36%)

Vera Therapeutics, Inc. Class A (VERA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.

The 50 SMA has sat below the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
below both $30.25 vs 50 $31.96 / 200 $36.88
Projection
No cross projected
Test
No active test
Last cross
Death cross 15 Jun 2026 ยท projected 23 bars out ยท tested 3 bars

Weekly as of 30 Oct 16:00 ET

Price
between the two $30.98 vs 50 $38.32 / 200 $28.92
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 13:30 ET

Price
between the two $30.89 vs 50 $29.65 / 200 $34.03
Projection
No cross projected
Test
No active test
Last cross
Death cross 5 Aug 2026 ยท projected 20 bars out

Cross history

19
crosses on record since 2022
9 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
5 Aug 2026Death4-hour20 bars outNot tested
14 Jul 2026Golden4-hour26 bars out5 bar cross test
15 Jun 2026Death moderatedaily23 bars out3 bar cross test
23 Mar 2026Death4-hour29 bars out7 bar cross test
22 Oct 2025Golden steepdaily27 bars outNot tested

About VERA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$50.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.